[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Bio_Scout Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::831637969.png) @Bio_Scout map

map posts on X about $rgnx, $clsd, $ocul, $eypt the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::831637969/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::831637969/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +117%

### Mentions: X [#](/creator/twitter::831637969/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::831637969/c:line/m:posts_active.svg)

- X Week X no change
- X Month X -XX%
- X Months XX -XXXX%
- X Year XX +9.80%

### Followers: XXX [#](/creator/twitter::831637969/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::831637969/c:line/m:followers.svg)

- X Week XXX +0.29%
- X Month XXX +0.29%
- X Months XXX +5.10%
- X Year XXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::831637969/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::831637969/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::831637969/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [technology brands](/list/technology-brands)  XXXX%

**Social topic influence**
[$rgnx](/topic/$rgnx) #5, [$clsd](/topic/$clsd) #1, [$ocul](/topic/$ocul) 4.17%, [$eypt](/topic/$eypt) 4.17%, [$abbv](/topic/$abbv) 4.17%, [phd](/topic/phd) XXXX%

**Top accounts mentioned or mentioned by**
[@clearsidebio](/creator/undefined) [@regenxbio](/creator/undefined) [@aao2025](/creator/undefined) [@biocrystpharma](/creator/undefined) [@blco](/creator/undefined) [@bauschlomb](/creator/undefined) [@clsd](/creator/undefined) [@abbvie](/creator/undefined) [@jeremyfalmouth](/creator/undefined)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv)
### Top Social Posts [#](/creator/twitter::831637969/posts)
---
Top posts by engagements in the last XX hours

"$RGNX $OCUL $EYPT $CLSD ASRS survey shows Retina Specialists are most excited about gene therapy for future treatment of Wet AMD.only XX% for TKIs. Don't shoot the messenger this is what the community of Retina Specialists are saying"  
[X Link](https://x.com/Bio_Scout/status/1953834245878604106) [@Bio_Scout](/creator/x/Bio_Scout) 2025-08-08T15:02Z XXX followers, 2182 engagements


"$RGNX @REGENXBIO @AAO2025 $ABBV $CLSD @clearsidebio LATE BREAKING ABSTRACT AT AAO NEXT WEEK for RGNX: Suprachoroidal Surabgene Lomparvovec (Sura-vec ABBV-RGX-314): First Time 2-Year Results in Non-Proliferative Diabetic Retinopathy Charles C Wykoff MD"  
[X Link](https://x.com/Bio_Scout/status/1975966187445256671) [@Bio_Scout](/creator/x/Bio_Scout) 2025-10-08T16:47Z XXX followers, XXX engagements


"$RGNX @REGENXBIO Dr. Khanani patient is 5+ years going strong on Regenxbio gene therapy: "My journey with sura-vec (formerly RGX-314) began during the Phase 1/2 trial where my enrolled patient remains injection-free to this day following a single dose.""  
[X Link](https://x.com/Bio_Scout/status/1975944891441279052) [@Bio_Scout](/creator/x/Bio_Scout) 2025-10-08T15:22Z XXX followers, XXX engagements


"$CLSD $RGNX @clearsidebio @REGENXBIO Late Breaking Abstract for the AAO conference Oct. 17-20th Suprachoroidal Surabgene Lomparvovec (Sura-vec ABBV-RGX-314): First Time 2-Year Results in Non-Proliferative Diabetic Retinopathy Dr. Wykoff MD PhD"  
[X Link](https://x.com/Bio_Scout/status/1961450257314623807) [@Bio_Scout](/creator/x/Bio_Scout) 2025-08-29T15:25Z XXX followers, XXX engagements